U.S. Markets open in 88 hrs, 10 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,543.55 | -171.63 | -1.47% |
| NASDAQ | 2,367.52 | -44.12 | -1.83% |
| S&P 500 | 1,282.82 | -17.86 | -1.37% |
| Day Low 03:40 PM EDT | 76.44 | |
|---|---|---|
| Day High 10:00 AM EDT | 77.63 |
|
| Range | 1.19 | |
| Volume | 812,174 | |
| 30-Day Avg. Vol. | 1.29 M |
|
| Difference | -37.33% | |
| Market Cap. | 5.2 B | |
| Change | -33.99 M | |
| Shares Out. | 67.98 M | |
| Percent Traded | 1.19% | |
| Revenue | 1.77 B | |
| Earnings | -191.7 M | |
| EPS (TTM) | -2.45 |
| 52-Wk Low 2/13/08 | 56.20 | |
|---|---|---|
| 52-Wk High 11/10/07 | 79.10 |
|
| Range | 22.90 | |
| Prev. Close 8/28/08 | 77.12 | |
| Today's Open | 76.61 | |
| Change | -0.66% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 0.889 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | 15.00 |
Cephalon isn't asleep at the wheel. The company sells PROVIGIL, a treatment for the sleep disorder narcolepsy, in the US and select countries around the world. The company's other top sellers are cancer ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.961 3/31/08 | 1.02 3/31/08 |
0.059
Beat
|
| Last Quarter | 1.073 6/30/08 | 1.13 6/30/08 |
0.057
Beat
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 492.72 M | 1.77 B |
| Gross Profit | 391.40 M | 1.40 B |
| Operating Income | 101.09 M | 333.06 M |
| Net Income | 60.07 M | -191.70 M |
Real-Time Quote
